Dose-Escalated Robotic SBRT for Stage I-II Prostate Cancer

Dose-Escalated Robotic SBRT for Stage I-II Prostate Cancer

Abstract: Stereotactic body radiotherapy (SBRT) is the precise external delivery of very high-dose radiotherapy to targets in the body, with treatment completed in one to five fractions. SBRT should be an ideal approach for organ-confined prostate cancer because (I) dose escalation should yield impr...

Full description

Bibliographic Details
Main Author:	Robert eMeier
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2015-04-01
Series:	Frontiers in Oncology
Subjects:	prostate cancer stereotactic body radiotherapy Hypofractionation robotic radiosurgery stereotactic ablative radiation therapy
Online Access:	http://journal.frontiersin.org/Journal/10.3389/fonc.2015.00048/full

Similar Items

Multi-institutional Registry for Prostate Cancer Radiosurgery: An Observational Clinical Trial
by: Debra eFreeman, et al.
Published: (2015-01-01)

Extreme Hypofractionation with SBRT in Localized Prostate Cancer
by: Maria Antonia Gómez-Aparicio, et al.
Published: (2021-08-01)

Survival Outcomes and Pattern of Relapse After SABR for Oligometastatic Prostate Cancer
by: Carole Mercier, et al.
Published: (2022-04-01)

Stereotactic body radiation therapy (SBRT) in the treatment of oligometastatic prostate cancer
by: Kamran Ali Ahmed, et al.
Published: (2013-01-01)

Clinical outcomes and toxicity using Stereotactic Body Radiotherapy (SBRT) for advanced cholangiocarcinoma
by: Barney Brandon M, et al.
Published: (2012-05-01)

PSMA-PET/MRI-Based Focal Dose Escalation in Patients with Primary Prostate Cancer Treated with Stereotactic Body Radiation Therapy (HypoFocal-SBRT): Study Protocol of a Randomized, Multicentric Phase III Trial
by: Constantinos Zamboglou, et al.
Published: (2021-11-01)

Acute side effects after definitive stereotactic body radiation therapy (SBRT) for patients with clinically localized or locally advanced prostate cancer: a single institution prospective study
by: Jorgo Kliton, et al.
Published: (2021-07-01)

Indications, feasibility, safety, and efficacy of CyberKnife radiotherapy for the treatment of olfactory groove meningiomas: a single institutional retrospective series
by: Jianmin Liu, et al.
Published: (2020-03-01)

A feasibility study of stereotactic radiosurgery/stereotactic body radiotherapy/stereotactic ablative radiotherapy practice using tomoedge in helical tomotherapy for lung, liver, and spine targets
by: N V. N. Madhusudhana Sresty, et al.
Published: (2021-01-01)

A phase II randomized trial of Observation versus stereotactic ablative RadiatIon for OLigometastatic prostate CancEr (ORIOLE)
by: Noura Radwan, et al.
Published: (2017-06-01)

Editorial: Novel Applications of Stereotactic Body Radiotherapy (SBRT)
by: Rupesh Kotecha, et al.
Published: (2021-09-01)

Normofractionated stereotactic radiotherapy versus CyberKnife-based hypofractionation in skull base meningioma: a German and Italian pooled cohort analysis
by: Conti Alfredo, et al.
Published: (2019-11-01)

The Judicious Use of Stereotactic Radiosurgery and Hypofractionated Stereotactic Radiotherapy in the Management of Large Brain Metastases
by: Tyler Gutschenritter, et al.
Published: (2020-12-01)

Feasibility of stereotactic body radiotherapy for locally-advanced non-small cell lung cancer
by: Katrina Woodford, et al.
Published: (2017-10-01)

Ultra-Hypofractionated Stereotactic Body Radiotherapy for Localized Prostate Cancer: Clinical Outcomes, Patterns of Recurrence, Feasibility of Definitive Salvage Treatment, and Competing Oncological Risk
by: Marcin Miszczyk, et al.
Published: (2022-09-01)

Editorial: The Evolving Landscape of Stereotactic Body Radiation Therapy for the Management of Prostate Cancer
by: Seth R. Blacksburg, et al.
Published: (2020-12-01)

SBRT for the Primary Treatment of Localized Prostate Cancer: The Effect of Gleason Score, Dose and Heterogeneity of Intermediate risk on Outcome Utilizing 2.2014 NCCN Risk Stratification Guidelines
by: Matthew eBernetich, et al.
Published: (2014-11-01)

Low Incidence of Fatigue after Hypofractionated Stereotactic Body Radiation Therapy (SBRT) for Localized Prostate Cancer
by: Chiranjeev eDash, et al.
Published: (2012-10-01)

Stereotactic Radiosurgery/Radiotherapy: A Historical Review
by: Mansoureh Nabavi, et al.
Published: (2014-04-01)

Effectiveness and Safety of Robotic Radiosurgery for Optic Nerve Sheath Meningiomas: A Single Institution Series
by: Carolin Senger, et al.
Published: (2021-04-01)

Stereotactic Radiation Therapy versus Brachytherapy: Relative Strengths of Two Highly Efficient Options for the Treatment of Localized Prostate Cancer
by: Manon Kissel, et al.
Published: (2022-04-01)

Treatment Optimization in Linac-Based SBRT for Localized Prostate Cancer: A Single-Arc versus Dual-Arc Plan Comparison
by: Denis Panizza, et al.
Published: (2023-12-01)

Factors influencing local control after MR-guided stereotactic body radiotherapy (MRgSBRT) for adrenal metastases
by: Gamze Ugurluer, et al.
Published: (2024-05-01)

Salvage robotic SBRT for local prostate cancer recurrence after radiotherapy: preliminary results of the Oscar Lambret Center
by: Thomas Leroy, et al.
Published: (2017-06-01)

Recent Advances in Radiotherapy Modalities for Prostate Cancer
by: Jure Murgić, et al.
Published: (2022-01-01)

Historical progress of stereotactic radiation surgery
by: Navid Khaledi, et al.
Published: (2023-01-01)

Hypofractionated Radiation Therapy for Large Brain Metastases
by: Giuseppina Laura Masucci
Published: (2018-10-01)

Is single fraction the future of stereotactic body radiation therapy (SBRT)? A critical appraisal of the current literature
by: M. Terlizzi, et al.
Published: (2023-03-01)

Volumetric reduction of brain metastases after stereotactic radiotherapy: Prognostic factors and effect on local control
by: Naoyuki Kanayama, et al.
Published: (2022-12-01)

Hypofractionated Radiotherapy in Localized, Low–Intermediate-Risk Prostate Cancer: Current and Future Prospectives
by: Maria Chiara Lo Greco, et al.
Published: (2023-06-01)

Dosimetric Impact of Intrafraction Prostate Motion and Interfraction Anatomical Changes in Dose-Escalated Linac-Based SBRT
by: Valeria Faccenda, et al.
Published: (2023-02-01)

Ten fraction hypofractionated stereotactic body radiotherapy for the management of ultracentral lung tumors: a retrospective analysis of dosimetry, outcomes, and toxicity
by: Crosby Rock, et al.
Published: (2023-08-01)

Long-term results and PSA kinetics after robotic SBRT for prostate cancer: multicenter retrospective study in Korea (Korean radiation oncology group study 15–01)
by: Younghee Park, et al.
Published: (2018-11-01)

Simultaneous optimization of radiation-imaging coincidence for a multi-energy linac
by: Cory Knill, et al.
Published: (2021-01-01)

A phase I dose-escalation trial of stereotactic body radiotherapy using 4 fractions for patients with localized prostate cancer
by: Takuro Kainuma, et al.
Published: (2019-09-01)

A framework for exactrac dynamic commissioning for stereotactic radiosurgery and stereotactic ablative radiotherapy
by: Ben Perrett, et al.
Published: (2022-01-01)

A multicenter prospective phase II study of postoperative hypofractionated stereotactic body radiotherapy (SBRT) in the treatment of early-stage oropharyngeal and oral cavity cancers with high risk margins: the STEREO POSTOP GORTEC 2017-03 trial
by: Julian Biau, et al.
Published: (2020-08-01)

Escalating a Biological Dose of Radiation in the Target Volume Applying Stereotactic Radiosurgery in Patients with Head and Neck Region Tumours
by: Paweł Polanowski, et al.
Published: (2022-06-01)

Highlights on the Management of Oligometastatic Disease
by: Salem M. Alshehri, et al.
Published: (2020-02-01)

Escalated Maximum Dose in the Planning Target Volume Improves Local Control in Stereotactic Body Radiation Therapy for T1-2 Lung Cancer
by: Takaya Inagaki, et al.
Published: (2022-02-01)